lead has been researched along with valproic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Carson, R; Haust, HL; Peter, F; Poon, HC; VanDeWetering, C | 1 |
| Lane, JD; Lasley, SM; Wimbish, GH | 1 |
| Aslam, M; Fernando, NP; Harrison, PG; Healy, MA | 1 |
| Bal-Price, AK; Coecke, S; Hartung, T; Hogberg, HT; Kinsner-Ovaskainen, A | 1 |
| Ba, Y; Cheng, X; Hu, Y; Huang, H; Li, W; Li, X; Su, Y; Wang, Y; Wu, Z; Zhang, H | 1 |
| Bal-Price, A; Bopp, SK; Carpi, D; Mendoza-de Gyves, E; Paini, A; Pistollato, F; Worth, A | 1 |
6 other study(ies) available for lead and valproic acid
| Article | Year |
|---|---|
Protoporphyrinaemia and decreased activities of 5-aminolevulinic acid dehydrase and uroporphyrinogen I synthetase in erythrocytes of a Vitamin B6-deficient epileptic boy given valproic acid and carbamazepine.
Topics: Ammonia-Lyases; Carbamazepine; Chromatography, Ion Exchange; Epilepsy; Erythrocytes; Folic Acid; Humans; Hydroxymethylbilane Synthase; Infant; Lead; Longitudinal Studies; Male; Porphobilinogen Synthase; Porphyrins; Protoporphyrins; Spectrometry, Fluorescence; Spectrophotometry, Atomic; Valproic Acid; Vitamin B 6 Deficiency | 1989 |
Valproate-induced accumulation of gamma-aminobutyric acid after chronic exposure to inorganic lead.
Topics: Animals; Brain Chemistry; Drug Interactions; gamma-Aminobutyric Acid; Globus Pallidus; Lead; Rats; Substantia Nigra; Tegmentum Mesencephali; Valproic Acid | 1986 |
Lead-induced convulsions in young infants--a case history and the role of GABA and sodium valproate in the pathogenesis and treatment.
Topics: Chemical Phenomena; Chemistry; Citric Acid Cycle; gamma-Aminobutyric Acid; Humans; Infant; Lead; Lead Poisoning; Male; Seizures; Valproic Acid | 1984 |
mRNA expression is a relevant tool to identify developmental neurotoxicants using an in vitro approach.
Topics: Animals; Animals, Newborn; Cell Differentiation; Cell Proliferation; Cell Survival; Cells, Cultured; Cerebellum; Dose-Response Relationship, Drug; Environmental Pollutants; Gene Expression Regulation; Genetic Markers; Glial Fibrillary Acidic Protein; Humans; Intermediate Filament Proteins; Lead; Methylmercury Compounds; Nerve Tissue Proteins; Nestin; Neurofilament Proteins; Neuroglia; Neurons; Neurotoxicity Syndromes; Rats; Rats, Wistar; Receptors, GABA-A; Receptors, N-Methyl-D-Aspartate; Risk Assessment; Risk Factors; RNA, Messenger; SOXE Transcription Factors; Time Factors; Toxicity Tests; Trimethyltin Compounds; Valproic Acid | 2010 |
Latent role of in vitro Pb exposure in blocking Aβ clearance and triggering epigenetic modifications.
Topics: Amyloid beta-Peptides; Cell Line; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Histones; Humans; Insulysin; Lead; Neprilysin; Tretinoin; Valproic Acid | 2019 |
Combining in vitro assays and mathematical modelling to study developmental neurotoxicity induced by chemical mixtures.
Topics: Astrocytes; Benzhydryl Compounds; Biological Assay; Brain-Derived Neurotrophic Factor; Cell Differentiation; Cell Survival; Cells, Cultured; Chlorpyrifos; Ethanol; Halogenated Diphenyl Ethers; Humans; Induced Pluripotent Stem Cells; Lead; Methylmercury Compounds; Models, Theoretical; Neural Stem Cells; Neurons; Neurotoxicity Syndromes; Oxazoles; Phenols; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Valproic Acid | 2021 |